GNLX
Price
$2.99
Change
-$0.06 (-1.97%)
Updated
Jun 27 closing price
Capitalization
112.45M
51 days until earnings call
VSTM
Price
$4.15
Change
-$0.01 (-0.24%)
Updated
Jun 27 closing price
Capitalization
228.04M
Interact to see
Advertisement

GNLX vs VSTM

Header iconGNLX vs VSTM Comparison
Open Charts GNLX vs VSTMBanner chart's image
Genelux
Price$2.99
Change-$0.06 (-1.97%)
Volume$76.94K
Capitalization112.45M
Verastem
Price$4.15
Change-$0.01 (-0.24%)
Volume$5.15M
Capitalization228.04M
GNLX vs VSTM Comparison Chart in %
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. VSTM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Buy and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GNLX: $2.99 vs. VSTM: $4.15)
Brand notoriety: GNLX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 52% vs. VSTM: 223%
Market capitalization -- GNLX: $112.45M vs. VSTM: $228.04M
GNLX [@Biotechnology] is valued at $112.45M. VSTM’s [@Biotechnology] market capitalization is $228.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, GNLX is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 5 TA indicator(s) are bullish while VSTM’s TA Score has 3 bullish TA indicator(s).

  • GNLX’s TA Score: 5 bullish, 4 bearish.
  • VSTM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than VSTM.

Price Growth

GNLX (@Biotechnology) experienced а +0.67% price change this week, while VSTM (@Biotechnology) price change was -15.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GNLX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($228M) has a higher market cap than GNLX($112M). GNLX YTD gains are higher at: 26.695 vs. VSTM (-19.729). GNLX has higher annual earnings (EBITDA): -28.78M vs. VSTM (-145.04M). VSTM has more cash in the bank: 118M vs. GNLX (35.1M). GNLX has less debt than VSTM: GNLX (1.79M) vs VSTM (76.8M). VSTM has higher revenues than GNLX: VSTM (10M) vs GNLX (0).
GNLXVSTMGNLX / VSTM
Capitalization112M228M49%
EBITDA-28.78M-145.04M20%
Gain YTD26.695-19.729-135%
P/E RatioN/AN/A-
Revenue010M-
Total Cash35.1M118M30%
Total Debt1.79M76.8M2%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNLXVSTM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TWODY17.240.36
+2.14%
Taylor Wimpey Plc
RGRNF3.10N/A
N/A
Regis Resources NL
BDORY4.03-0.05
-1.23%
Banco Do Brasil SA
NTCPF0.82-0.06
-6.47%
Northisle Copper & Gold Inc.
NSGCF0.02N/A
-9.37%
NORTHSTAR GOLD CORP.

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-1.97%
VSTM - GNLX
48%
Loosely correlated
-0.24%
SYRE - GNLX
31%
Poorly correlated
-4.99%
CGON - GNLX
31%
Poorly correlated
-0.46%
SNSE - GNLX
30%
Poorly correlated
+3.58%
BEAM - GNLX
30%
Poorly correlated
-1.98%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-0.24%
GNLX - VSTM
48%
Loosely correlated
-1.97%
SNSE - VSTM
46%
Loosely correlated
+3.58%
NKTX - VSTM
41%
Loosely correlated
-3.18%
IPSC - VSTM
41%
Loosely correlated
-5.74%
SYRE - VSTM
40%
Loosely correlated
-4.99%
More